Platelets in chronic liver disease, from bench to bedside

被引:52
|
作者
Ramadori, Pierluigi [1 ]
Klag, Thomas [2 ]
Malek, Nisar Peter [2 ]
Heikenwalder, Mathias [1 ]
机构
[1] German Canc Res Ctr Heidelberg DKFZ, Div Chron Inflammat & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[2] Univ Tubingen, Dept Internal Med 1, Muller Str 10, D-72076 Tubingen, Germany
关键词
Platelets; cirrhosis; HCC; cancer; immune system; immunology; NASH; NAFLD; LOW-DOSE ASPIRIN; HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR; PARTIAL-HEPATECTOMY; IMPROVES SURVIVAL; HCV INFECTION; KUPFFER CELLS; DRUG-THERAPY; MOUSE MODEL; LIFE-SPAN;
D O I
10.1016/j.jhepr.2019.10.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In the last decade, numerous studies revealed physiologic and pathophysiologic roles of platelets beyond haemostasis, a process to prevent and stop bleeding. These include the activation of the immune system and the promotion of inflammation, infection and cancer. Hence, the emerging view on the role of platelets has shifted - platelets are nowseen as alert "sentinels" of the immune compartment, rather than passive bystanders. Herein, we review well-established and newly discovered features of platelets that define their natural role in maintaining blood haemostasis, but also their functional relationship with other cells of the immune system. We focus on recent studies underlining functional involvement of platelets in chronic liver diseases and cancer, as well as the effects of anti-platelet therapy in these contexts. Finally, we illustrate the potential of platelets as possible diagnostic and therapeutic tools in liver disease based on recently developed methodologies. (c) 2019 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:448 / 459
页数:12
相关论文
共 50 条
  • [31] Refractory celiac disease: from bench to bedside
    Georgia Malamut
    Bertrand Meresse
    Christophe Cellier
    Nadine Cerf-Bensussan
    Seminars in Immunopathology, 2012, 34 : 601 - 613
  • [32] Inflammatory Bowel Disease - From Bench to Bedside
    Fichna, Jakub
    CURRENT DRUG TARGETS, 2020, 21 (14) : 1396 - 1396
  • [33] Obesity and vascular disease: From bench to bedside
    Alessi, Marie-Christine
    Wojta, Johann
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (04) : 632 - 633
  • [34] Parkinson's disease: From bench to bedside
    Draoui, A.
    El Hiba, O.
    Aimrane, A.
    El Khiat, A.
    Gamrani, H.
    REVUE NEUROLOGIQUE, 2020, 176 (7-8) : 543 - 559
  • [35] The cellular origins of disease - from bench to bedside
    Green, Kathleen J.
    JOURNAL OF CELL SCIENCE, 2012, 125 (17) : 3921 - 3922
  • [36] Refractory celiac disease: from bench to bedside
    Malamut, Georgia
    Meresse, Bertrand
    Cellier, Christophe
    Cerf-Bensussan, Nadine
    SEMINARS IN IMMUNOPATHOLOGY, 2012, 34 (04) : 601 - 613
  • [37] Peritoneal dialysis: from bench to bedside and bedside to bench
    Perl, Jeffrey
    Bargman, Joanne M.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 311 (05) : F999 - F1004
  • [38] Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
    Pelliccia, Francesco
    Morgantini, Amalia
    Rosati, Riccardo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [39] Chronic myocardial hibernation in humans - From bedside to bench
    Vanoverschelde, JLJ
    Wijns, W
    Borgers, M
    Heyndrickx, G
    Depre, C
    Flameng, W
    Melin, JA
    CIRCULATION, 1997, 95 (07) : 1961 - 1971
  • [40] Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back
    Yilmaz, Yusuf
    Colak, Yasar
    Kurt, Ramazan
    Senates, Ebubekir
    Eren, Fatih
    TUMORI JOURNAL, 2013, 99 (01): : 10 - 16